Kevin Mayo, PhD
Global Head, Market Access
Dr. Mayo supports therapeutic product development for PTC’s gene therapy, alternative splicing, transcript regulation, and missense readthrough platforms. He completed a master’s degree in Neuropsychology and a Doctoral degree in Pharmaceutical Marketing and Administration. More recently Dr. Mayo earned an Executive Juris Doctorate in Health Law and Policy. He has served on the adjunct faculties for the Mayes College of Healthcare Business and Policy (University of the Sciences) and the College of Population Health (Thomas Jefferson University) and is a frequent presenter at international market access conferences. He received a Distinguish Service Award from the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) for his contribution to the society.